Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Influenza, Human 2

Interventions

Influenza Vaccines 13trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine 2Vaccines 2Oseltamivir 2FluMist 2Cyclophosphamide 2vaxigrip 1thymoglobulin 1peginterferon alfa-2a 1influvac 1fludarabine 1baloxavir 1Starch 1SARS-CoV-2 inactivated vaccines 1Rituximab 1Nivolumab 1Melphalan 1Levetiracetam 1Lenalidomide 1Ipilimumab 1Interferons 1Interferon alpha-2 1Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Fluzone High-Dose 1Diphtheria-Tetanus Vaccine 1Celecoxib 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Influenza, Human × FluMist × Clear all
NCT00112112 2017-08-14

Safety Study to Evaluate FluMist in Immunocompromised Children

MedImmune LLC

Phase 1 Completed
20 enrolled 70 charts

Influenza, Human, Neoplasms

NCT00906750 2011-10-13

FMRESP

St. Jude Children's Research Hospital

Phase 1 Completed
56 enrolled

Influenza, Human, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡